# Cidofovir in Renal Transplant Recipients With BKVN

> **NCT00138424** · PHASE1,PHASE2 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 22 (actual)

## Conditions studied

- BK Virus (Nephropathy)

## Interventions

- **DRUG:** Cidofovir
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00138424
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-05
- **Primary completion:** 2010-06
- **Final completion:** 2011-04
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2013-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00138424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00138424, "Cidofovir in Renal Transplant Recipients With BKVN". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00138424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*